Related references
Note: Only part of the references are listed.Hemolytic events associated with intravenous immune globulin therapy: a qualitative analysis of 263 cases reported to four manufacturers between 2003 and 2012
Roger Berg et al.
TRANSFUSION (2015)
Management of Kawasaki disease
D. Eleftheriou et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2014)
Intravenous immunoglobulin in isoimmune haemolytic disease of newborn: an updated systematic review and meta-analysis
Deepak Louis et al.
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION (2014)
Regulatory T cell microRNA expression changes in children with acute Kawasaki disease
F-F. Ni et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
Kawasaki disease Part II. Complications and treatment
Stephanie Bayers et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2013)
Pediatric Acute Transverse Myelitis Overview and Differential Diagnosis
Varina L. Wolf et al.
JOURNAL OF CHILD NEUROLOGY (2012)
Hemolytic anemia following intravenous immunoglobulin therapy in patients treated for Kawasaki disease: a report of 4 cases
Roberta Berard et al.
PEDIATRIC RHEUMATOLOGY (2012)
A pediatric case series of acute hemolysis after administration of intravenous immunoglobulin
David J. Gordon et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Intravenous Immunoglobulin and Salicylate Differentially Modulate Pathogenic Processes Leading to Vascular Damage in a Model of Kawasaki Disease
Andrew C. Lau et al.
ARTHRITIS AND RHEUMATISM (2009)
Molecular Genetics of Kawasaki Disease
Yoshihiro Onouchi
PEDIATRIC RESEARCH (2009)
Hemolytic transfusion reactions after administration of intravenous immune (gamma) globulin: a case series analysis
Zohra Daw et al.
TRANSFUSION (2008)
Use of intravenous immunoglobulin in human disease: A review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology
JS Orange et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, Council on Cardiovascular Disease in the Young, American Heart Association
JW Newburger et al.
PEDIATRICS (2004)
Risks associated with the use of intravenous immunoglobulin
LR Pierce et al.
TRANSFUSION MEDICINE REVIEWS (2003)
Cytokine modulation with immune γ-globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment
M Gupta et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2001)
Share Paper
